All Stories

  1. Strategical Analysis of Cyberbiosecurity in 2022: How to Defend Biotech and Healthcare Sector from Cyber Treats

    Article • August 2022, Institute of Electrical & Electronics Engineers (IEEE)

    Daniel Cebo

  2. Strategical Analysis of Cyberbiosecurity in 2022: How to Defend Biotech and Healthcare Sector from Cyber Treats

    Article • August 2022, Institute of Electrical & Electronics Engineers (IEEE)

    Daniel Cebo

  3. Experimental Models of Drug Metabolism and Distribution in Drug Design and Development    

    Article • June 2022, Authorea, Inc.

    Daniel Cebo

  4. Application of Cyborgs and Enhancement Technology in Biomedical Engineering    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  5. CD4 T follicular helper cells in HIV    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  6. Scientific Relevance and Future of Digital Immortality and Virtual Humans    

    Article • May 2022, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  7. Singularity: Non-Biological Artificial General Intelligence

    Article • SSRN Electronic Journal, January 2022, Elsevier

    Daniel Cebo

  8. Internet drug trading: national review of new online drug markets for young people

    Article • May 2021, Authorea, Inc.

    Prof.Dr. Daniel Cebo, Daniel Cebo

  9. Review of "HIV Infection and Cardiovascular Disease"

    Article • March 2020, Publons

    Prof.Dr. Daniel Cebo, Daniel Cebo

  10. Human Enhancement

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Daniel Cebo

  11. Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease

    Article • Neurogenetics, September 2009, Springer Science + Business Media

    Professor Ferdinand von Eggeling, Prof.Dr. Daniel Cebo, Daniel Cebo